These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 7500697)

  • 1. [Bayer and calcium blockers].
    Lindeberg S
    Lakartidningen; 1995 Nov; 92(47):4404. PubMed ID: 7500697
    [No Abstract]   [Full Text] [Related]  

  • 2. [Supposedly, calcium channel blockers cause infarction. Then the Bayer company took over the press conference].
    Werkö L
    Lakartidningen; 1995 Oct; 92(43):3982, 3985. PubMed ID: 7475523
    [No Abstract]   [Full Text] [Related]  

  • 3. [We don't receive sufficient information about calcium blockers and other drugs].
    Lindeberg S
    Lakartidningen; 1995 Oct; 92(43):3977. PubMed ID: 7475518
    [No Abstract]   [Full Text] [Related]  

  • 4. [Drug information: a company convicted for advertising without permission from the Medical Products Agency].
    Lakartidningen; 1997 Feb; 94(6):449. PubMed ID: 9053698
    [No Abstract]   [Full Text] [Related]  

  • 5. ["The safety of drugs a stepchild of medicine". Calcium blockers not the only example].
    Karlsson Y
    Lakartidningen; 1996 Oct; 93(43):3804-6. PubMed ID: 8965557
    [No Abstract]   [Full Text] [Related]  

  • 6. [Evaluation of calcium antagonists--a question for the SBU].
    Philip-Shansky A; Higham P
    Lakartidningen; 1995 Nov; 92(44):4076. PubMed ID: 8538266
    [No Abstract]   [Full Text] [Related]  

  • 7. [Strictly forbidden fruit?].
    Bergstrand CG
    Lakartidningen; 2001 Oct; 98(43):4758. PubMed ID: 11715258
    [No Abstract]   [Full Text] [Related]  

  • 8. Conflict of interest in the debate over calcium-channel antagonists.
    Opie L
    N Engl J Med; 1998 Jun; 338(23):1696-7; author reply 1697-8. PubMed ID: 9616064
    [No Abstract]   [Full Text] [Related]  

  • 9. Living up to 100 years of Bayer Healthcare cardiovascular protection - Bayer Healthcare Cardiovascular : 20 years of participation in the South African cardiovascular community.
    Cardiovasc J Afr; 2009; 20(1):91-4. PubMed ID: 19287826
    [No Abstract]   [Full Text] [Related]  

  • 10. [Tax payers have payed billions for the "blood pressure maffia's" actions].
    Järhult B; Lindahl SO
    Lakartidningen; 2003 May; 100(21):1917-8. PubMed ID: 12815880
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinically significant drug-drug and drug-food interactions associated with calcium channel blockers].
    Imaura M; Ohno Y; Nakajima K; Suzuki H
    Clin Calcium; 2005 Oct; 15(10):1709-16. PubMed ID: 16199918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comment on the information by the Federal Drug and Medical Products Institute on "calcium channel blockers of the 1,4-dihydropyridine class"].
    Trenkwalder P
    Internist (Berl); 1995 Jul; 36(7):730-1. PubMed ID: 7672923
    [No Abstract]   [Full Text] [Related]  

  • 13. The safety of calcium channel blockers during pregnancy: a prospective, multicenter, observational study.
    Weber-Schoendorfer C; Hannemann D; Meister R; Eléfant E; Cuppers-Maarschalkerweerd B; Arnon J; Vial T; Rodriguez-Pinilla E; Clementi M; Robert-Gnansia E; De Santis M; Malm H; Dolivo A; Schaefer C
    Reprod Toxicol; 2008 Sep; 26(1):24-30. PubMed ID: 18585452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. "Drug may have caused huge number of deaths": lessons learned during an encounter with The Fifth Estate.
    Myers MG
    CMAJ; 1996 Sep; 155(6):772-5. PubMed ID: 8823222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The safety of calcium-channel blockers.
    Massie BM
    Clin Cardiol; 1998 Dec; 21(12 Suppl 2):II12-7. PubMed ID: 9853194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of calcium channel blockers and risk of suicide. Perscriptions for particular drug are influenced by numerous factors.
    Chen YT; Makuch RW
    BMJ; 1998 Oct; 317(7165):1077. PubMed ID: 9841040
    [No Abstract]   [Full Text] [Related]  

  • 17. Gingival overgrowth with calcium-channel blockers. Treatment options.
    Palattella A; Marano G; Bollero P; Tomarelli F
    Minerva Stomatol; 2005 Jun; 54(6):339-49. PubMed ID: 16175163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcium channel blockers in the treatment of hypertension.
    Raspa RF; Wilson CC
    Am Fam Physician; 1993 Sep; 48(3):461-70. PubMed ID: 8362695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of calcium channel blockers and risk of suicide. Drug perscriptions over longer period should have been followed up.
    Wiholm BE; Sundström A; Alfredsson L
    BMJ; 1998 Oct; 317(7165):1076-7. PubMed ID: 9841039
    [No Abstract]   [Full Text] [Related]  

  • 20. Calcium channel blockers, cancer incidence, and cancer mortality in a cohort of U.S. women: the nurses' health study.
    Michels KB; Rosner BA; Walker AM; Stampfer MJ; Manson JE; Colditz GA; Hennekens CH; Willett WC
    Cancer; 1998 Nov; 83(9):2003-7. PubMed ID: 9806660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.